Status:
COMPLETED
Oxycodone User Registry (OUR)
Lead Sponsor:
Ortho-McNeil Janssen Scientific Affairs, LLC
Conditions:
Pain
Eligibility:
All Genders
18-85 years
Brief Summary
The purpose of this study is to describe clinical and demographic characteristics of patients receiving prescription medications containing oxycodone immediate release (OXYRX), to characterize patient...
Detailed Description
Real-world utility of Schedule II immediate release opioids depends on both efficacy and side effects. Few existing data sources systematically captured opioid-related side effects and their impact on...
Eligibility Criteria
Inclusion
- Pain requiring treatment with a Schedule II immediate release opioid within 3 days following the baseline visit
- and pain that warrants treatment with a prescription for OXYRX PRN (alone or in combination) for at least 5 days after the baseline visit
Exclusion
- Use of any Schedule II opioid within 30 days prior to informed consent
- planned use of other opioids (Schedule II-V) while using OXYRX
- malignancy other than superficial skin cancers (ie, basal cell, squamous cell) within the past year
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
827 Patients enrolled
Trial Details
Trial ID
NCT00978328
Start Date
June 1 2009
End Date
January 1 2010
Last Update
April 2 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.